
GenoPalate
GenoPalate analyzes genetic data, demographics and lifestyle information to deliver personalized insights for optimal healthy eating.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
* | N/A | $5.6m | Early VC |
Total Funding | 000k |
USD | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | 163 % | 24 % | - | - |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
GenoPalate, founded in 2016 by Dr. Sherry Zhang, a molecular biologist, is a company that specializes in personalized nutrition based on an individual's genetic makeup. Dr. Zhang's research in obesity and metabolism led her to the conclusion that a one-size-fits-all approach to dieting is ineffective, which sparked the idea for GenoPalate. The company has since raised $15.4 million in funding to support its growth and development.
GenoPalate's primary offering is an at-home DNA testing kit that analyzes a person's genetic information to provide personalized dietary recommendations. The process begins with the customer providing a saliva sample, which is then sent to GenoPalate's lab for analysis. The company's proprietary algorithm, developed by a team of scientists and dietitians, analyzes over 100 genetic markers known to influence how the body processes food and nutrients. Based on this analysis, GenoPalate generates a comprehensive report that includes personalized recommendations for macronutrients, vitamins, and minerals, as well as a list of over 85 foods that are most compatible with the individual's genetic profile. The company also offers personalized recipes and supplements to complement its dietary recommendations.
GenoPalate operates on a direct-to-consumer business model, selling its DNA testing kits and personalized nutrition plans directly to customers through its website. The company also partners with healthcare professionals and corporate wellness programs to offer its services to a wider audience. GenoPalate's target market includes individuals who are looking to optimize their health, manage their weight, or address specific health concerns through a personalized approach to nutrition.
Keywords: personalized nutrition, genetic testing, nutrigenomics, DNA-based diet, metabolic health, wellness, direct-to-consumer, health-tech, food-tech, supplements